Results of recent systematic reviews suggest favorable results of embolization for the treatment of Pelvic Congestion Syndrome (PCS) compared with pre-procedure symptoms for several outcomes, including pain reduction, overall patient satisfaction, and technical feasibility. Reported complication rates appears relatively low. Pelvic vein embolization is a relatively new technology and the results may provide background for an evidence based decision to offer embolization of pelvic varicosities for women with PCS in Norway.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
3
Embolization of pelvic vein varicosities
St Olavs Hospital
Trondheim, Norway
chronic pelvic pain
assessed by a numeric rating scale (0-10) within the questionnaire of the Norwegian Society for Pain
Time frame: 3 months
chronic pelvic pain
assessed by a numeric rating scale (0-10) within the questionnaire of the Norwegian Society for Pain
Time frame: 6 months
chronic pelvic pain
assessed by a numeric rating scale (0-10) within the questionnaire of the Norwegian Society for Pain
Time frame: 1 year
Health related quality of life (HRQOL)
based on the SF-8 and mental health measurements based on the 5-mental health inventory
Time frame: 3 months
Health related quality of life (HRQOL)
based on the SF-8 and mental health measurements based on the 5-mental health inventory
Time frame: 6 months
Health related quality of life (HRQOL)
based on the SF-8 and mental health measurements based on the 5-mental health inventory
Time frame: 1 year
Sexual function
assessed with a short screening tool for sexual dysfunction, containing 4 questions plus 6 sub-questions (Hatzichristou D et al. J Sex Med 2004) - Norwegian translation (non-validated)
Time frame: 3 months
Sexual function
assessed with a short screening tool for sexual dysfunction, containing 4 questions plus 6 sub-questions (Hatzichristou D et al. J Sex Med 2004) - Norwegian translation (non-validated)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 6 months
Sexual function
assessed with a short screening tool for sexual dysfunction, containing 4 questions plus 6 sub-questions (Hatzichristou D et al. J Sex Med 2004) - Norwegian translation (non-validated)
Time frame: 1 year